Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
about
Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primerIL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseInterleukin-23 drives innate and T cell-mediated intestinal inflammationIL-23 receptor (IL-23R) gene protects against pediatric Crohn's diseaseFibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyInflammatory pathways of importance for management of inflammatory bowel diseaseInterleukin-23: as a drug target for autoimmune inflammatory diseasesImpacts of cigarette smoking on immune responsiveness: Up and down or upside down?Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implicationContribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotypeDecreased expression of interleukin-27 in immune thrombocytopenia.Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humansPotential role of ustekinumab in the treatment of chronic plaque psoriasisLipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophagesInterleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2ADexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages.Th17-related cytokines: new players in the control of chronic intestinal inflammationTreatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c miceIL-27-induced modulation of autoimmunity and its therapeutic potential.IL-27 promotes T cell-dependent colitis through multiple mechanisms.The WSX-1 pathway restrains intestinal T-cell immunityIL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.Preclinical development of AMG 139, a human antibody specifically targeting IL-23Experimental infection of a bovine model with human isolates of Mycobacterium avium subsp. paratuberculosisGastric epithelial expression of IL-12 cytokine family in Helicobacter pylori infection in human: is it head or tail of the coin?Microbiota regulation of inflammatory bowel disease and colorectal cancer.Potential role of NK cells in the pathogenesis of inflammatory bowel disease.Genetic deletion of IL-25 (IL-17E) confers resistance to dextran sulfate sodium-induced colitis in miceInduction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 productionP-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis.Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis.Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesisIncreased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.
P2860
Q24596756-18B5081C-011A-446D-877E-40F5CD998E05Q24645890-6EDBEE72-D80E-44B1-8606-9E150F585509Q24677051-6229690D-7E9C-4AB4-AE31-B314AD326B83Q24681096-6C720142-C4EB-4BB7-9873-6026C7406455Q26801150-B60EF967-410D-4F28-B2C8-7761175A810EQ27005445-54C1E170-41AA-4A1A-86F1-F2B5319BB6E2Q27009502-539F3B00-B4F2-4C8B-8D47-8DE2B713F85AQ28072341-C0B22154-04A0-4DAA-BE4C-BD6E6CECCAF1Q28265856-5F4E9EE3-39A2-4880-8761-B54F3275DBBFQ28302755-7292C1AC-7E96-4845-AFA2-BC9B04DCF8E6Q33394417-245BB1A7-D788-478F-9CBA-55E5BD22F848Q33440583-1B2C5CBD-B38A-4852-BF30-BDFEF3015C03Q33590409-82249CF5-1B09-4312-BFCE-7630251B4EA2Q33670036-21CC55E3-308B-41F5-8E59-BBE881F6710AQ33833964-939F7D72-D47E-423B-B39C-3443AA0DFCAFQ33892602-751F615D-EA97-40D6-A65F-F6DA3734915CQ33919041-24D28D44-E823-43F7-A314-E46183E7A6C3Q33929587-2E3F2CFD-2E16-424F-92D5-43151A8BC153Q33972053-616AC48A-864F-4780-8937-6D806017096CQ34074137-EB7DEBC1-F722-416B-BA06-51A2499F0029Q34084499-7AE454BD-E667-419A-91DD-34D7B54B7CADQ34488647-61D75931-04D1-454A-9CA6-ED6AC7B00279Q34488727-5B5D9B83-3120-4760-ADB6-6B133DD8D736Q34501413-9918A067-8EAA-40DF-81CA-956AC0183B50Q34538706-8D0B8B80-8636-4F8D-8C6B-8C2482EDA109Q34572769-1069427C-F025-4AF9-9130-DCC3B20A0F84Q34662156-9F264E09-6B8E-42D7-9D41-C3DF0CC714C9Q34792941-5F3A77C0-62A4-4D65-9C19-9E6F1CE616E3Q34795742-248D689B-5BDC-482B-AC77-CD9C9D901784Q34989497-A48A8AD4-9733-435A-AED5-5863A7706543Q34999507-70A04661-AC39-485B-894F-E7F2A01E65E1Q35000300-5D041D1A-74F4-4C68-8B0A-90FD35BDCF7EQ35043975-8E12E976-2913-41B6-9915-A212698A00B8Q35563351-4CEF93BE-EFB5-4199-BF66-BD71A814800FQ35592657-8246CB6A-E830-417F-A056-A34C1D558DF7Q35644280-D1E743F1-47E7-458B-B916-E295F19C54E1Q35685556-83700A0C-10AC-4D74-B58E-CDFD352B739EQ35699353-2C18F556-B827-4959-B90B-93EB2F275EA1Q35725815-BB765788-3873-4EFD-9C59-B50DC636968DQ35860851-9755B3F3-FE01-449A-A30C-24C4788F4C5B
P2860
Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@en
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@nl
type
label
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@en
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@nl
prefLabel
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@en
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@nl
P2093
P2860
P1476
Expression of interleukin-12-r ...... but not in ulcerative colitis.
@en
P2093
Andreas Stallmach
Bianca Ludwig
Carsten Schmidt
Ina Mueller-Molaian
Stefan C Meuer
Thomas Giese
Thomas Marth
P2860
P356
10.1097/00054725-200501000-00003
P577
2005-01-01T00:00:00Z